Limb Girdle Muscular Dystrophy Type 2F (LGMD2F)

Sponsored diagnostic testing programs for Limb Girdle Muscular Dystrophy Type 2F (LGMD2F)

Limb-Girdle Muscular Dystrophy Type 2F (LGMD2F) is a rare, inherited neuromuscular disorder caused by pathogenic variants in the SGCD gene, which encodes δ-sarcoglycan. The condition leads to progressive weakness of the shoulder and hip muscles, often beginning in childhood or adolescence. Over time, individuals may experience difficulty walking, climbing stairs, or rising from the floor, and some may develop cardiomyopathy or respiratory involvement.

1 program found for Limb Girdle Muscular Dystrophy Type 2F (LGMD2F)

Programs

1 program
Invitae Unlock™

Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel

The Invitae Unlock™ Cardiomyopathy & Arrhythmia program offers sponsored genetic testing for U.S. patients with suspected inherited cardiomyopathy or arrhythmia. The comprehensive panel supports diagnostic clarification, risk assessment, and family variant identification. The test is billed to insurance first; when a claim is denied or the patient is uninsured, the program's sponsor covers the cost of testing. Testing must be ordered by a qualified healthcare provider.

Cardiology
ViewOrder
Performing lab
Invitae | Labcorp